NR1H4 and metabolic dysfunction-associated steatotic liver disease: Bile acids mainly modulate inflammation and lipid and glucose metabolism through liver FXR and G protein-coupled bile acid receptor 1 (GPBAR1), especially VLDL and triglyceride production, de novo fatty acid synthesis and IR, ultimately regulating the progression of CVD in NAFLD patients (120).